Metodbevispost

Matched Phase IV Study

A Matched Phase IV study is a post-marketing observational design in which patients who received an approved drug (or intervention) are matched to comparable non-exposed patients — or patients on an alternative therapy — to evaluate real-world safety, effectiveness, or long-term outcomes. Conducted after regulatory approval, it combines the epidemiological rigour of matching with the breadth of post-authorization pharmacovigilance, generating evidence that randomized trials are rarely powered or timed to provide.

Sources recorded, not reviewed

Källpost

Citat kopierade ordagrant från metodens källpost. Ingen verifiering på källnivå härleds från dem.

Matched Phase IV Post-Marketing Study

Taxonomisk metodpost · process-pipeline / epidemiology

Strom, B. L., & Kimmel, S. E. (Eds.). (2005). Textbook of Pharmacoepidemiology. Wiley. · ISBN 978-0470029244
Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. · DOI 10.1093/biomet/70.1.41

Öppna fullständig metod

Kuraterade påståenden

Påståenden lagrade i bevisloggen, var och en med sin egen bedömning.

Inga kuraterade påståenden ännu

Denna vy hittar inte på en påståendebedömning när loggen saknar en.

Relaterade metoder

Genererade från metodgrafen och visade som maskinföreslagna relationer – inga bevispåståenden härleds.

Taxonomic bucketCase-control studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.See alsoInterrupted Time Seriesmachine-suggested · Relational suggestion, not evidence.See alsoInverse Probability Weightingmachine-suggested · Relational suggestion, not evidence.Same method familyPropensity Score Matchingmachine-suggested · Relational suggestion, not evidence.